Rising Cardiovascular Disease Rates Drive Expansion Of Lisinopril Market : Pivotal Factor Influencing Lisinopril Market Growth in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Lisinopril Market Size Growth Forecast: What to Expect by 2025?
The market size of lisinopril has been expanding robustly in the past few years. This market is projected to boost from $1.76 billion in 2024 to $1.88 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. Factors like improved access, changes in lifestyle, enhanced screening initiatives, the growing availability of generic lisinopril, and better patient compliance have contributed to its growth during the historic period.

How Will the Lisinopril Market Size Evolve and Grow by 2029?
In the coming years, robust growth is anticipated for the lisinopril market, projecting a rise to $2.4 billion by 2029 at a 6.3% compound annual growth rate (CAGR). This growth during the forecasted period can be ascribed to a surge in hypertension and cardiovascular disease incidences, the availability of generic versions and cost-effectiveness, increased consciousness and early detection, the rising need for potent treatments, and an aging population. The forecast period also exhibits key trends such as drug delivery innovations, the requirement for improved and patient-focused drug delivery strategies, a call for cost-efficient remedies, a demand for effective heart failure treatments, and a strong demand for effective treatments for diabetic kidney ailment.

View the full report here:
https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report

What Drivers Are Propelling the Growth of Lisinopril Market Forward?
The escalating occurrence of cardiovascular ailments is projected to fuel the lisinopril market's expansion. Cardiovascular diseases (CVDs), disorders affecting both the heart and blood vessels, are becoming more common for diverse reasons, including population growth and ageing, multiple risk factors, and lack of application of evidence-based prevention and treatment methods. Lisinopril assists in the management of these diseases chiefly by reducing blood pressure, consequently lessening the burden on the heart and kidneys. It restricts angiotensin II production, promotes blood vessels' dilation, decreases blood volume, and protects organs from harm. For example, the Singapore Heart Foundation (SHF), a non-profit organisation based in Singapore, reported that ischemic heart diseases caused 5,302 fatalities in May 2024, a slight climb from 5,290 in 2022. Hence, the rising prevalence of cardiovascular diseases is accelerating the lisinopril market's growth. Transitioning to another important driver of the lisinopril market - the escalating pervasiveness of hypertension is predicted to fuel the expansion of the lisinopril market. Hypertension, or high blood pressure, is a condition where the blood's force against artery walls is too high consistently. This surge in hypertension prevalence is tied to an unhealthy diet, lack of physical activity, an ageing population, and prolonged stress. Lisinopril is an efficient medicine for controlling hypertension by inhibiting the formation of angiotensin II, leading to the relaxation of blood vessels, reduced blood volume, and lowered blood pressure. According to the World Health Organization, a health organization based in Switzerland, approximately 1.28 billion adults between the ages of 30 and 79 globally had hypertension in March 2023. Therefore, the growing incidence of hypertension is propelling the lisinopril market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16465&type=smp

What Are the Key Segments in the Lisinopril Market?
The lisinopril market covered in this report is segmented -

1) By Brand: Zestoretic, Prinivil, Zestril, Other Brands
2) By Disease: Hypertension, Heart Failure, Heart Attack, Strokes, Diabetic Kidney Disease, Other Diseases
3) By Dosage: Tablet, Liquid, Other Dosages
4) By Population Type: Children, Adults
5) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:
1) By Zestoretic: Different Dosage Forms, Generic Versions Of Zestoretic
2) By Prinivil: Different Dosage Forms, Generic Versions Of Prinivil
3) By Zestril: Different Dosage Forms, Generic Versions Of Zestril
4) By Other Brands: International Brand Variants, Combination Drug Formulations

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16465&type=smp

Who Are the Key Players Shaping the Lisinopril Market's Competitive Landscape?
Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., AbbVie Inc., AstraZeneca Plc, Vitaris Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Hetero Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Metrochem API Private Limited, Calyx Chemicals & Pharmaceuticals Limited, Farmhispania Group, Zydus Cadila Healthcare Ltd., Qingdao Qingmei Biotech Co. Ltd., LGM Pharma LLC, Amara Labs Pvt., Sms Lifesciences

What Geographic Markets Are Powering Growth in the Lisinopril Market?
North America was the largest region in the lisinopril market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16465

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.